实验旨在阐明牛酰基辅酶A氧化酶1(Acyl-Co A Oxidase 1,ACOX1)在肌内脂肪沉积过程中的作用,为优质肉牛品种培育提供理论依据。首先扩增牛ACOX1基因的CDS序列,构建ACOX1基因的过表达载体,然后将过表达载体转染3T3-L1细胞,利用油红O染色...实验旨在阐明牛酰基辅酶A氧化酶1(Acyl-Co A Oxidase 1,ACOX1)在肌内脂肪沉积过程中的作用,为优质肉牛品种培育提供理论依据。首先扩增牛ACOX1基因的CDS序列,构建ACOX1基因的过表达载体,然后将过表达载体转染3T3-L1细胞,利用油红O染色技术检测脂滴沉积情况,利用荧光定量PCR、Western blotting技术检测成脂分化基因PPARγ及C/EBPα的表达量。BLAST分析及酶切鉴定结果显示,成功构建了牛ACOX1基因的过表达载体;油红O结果表明,过表达ACOX1基因抑制了3T3-L1细胞的脂滴沉积;荧光定量PCR及Western blotting结果表明,过表达ACOX1基因显著性抑制了C/EBPα的表达量而对PPARγ的表达量无显著性影响。本研究结果显示,ACOX1可能抑制肌内脂肪沉积。展开更多
文章通过分析酰基辅酶A氧化酶(Acyl-Coenzyme A Oxidases 3,ACOX3)基因单核苷酸多态性与鸡脂肪性状的关系,旨在了解该基因对鸡体脂沉积的影响。以东北农业大学高、低脂双向选择品系肉鸡为材料,采用PCR-RFLP方法检测ACOX3基因的多态性,...文章通过分析酰基辅酶A氧化酶(Acyl-Coenzyme A Oxidases 3,ACOX3)基因单核苷酸多态性与鸡脂肪性状的关系,旨在了解该基因对鸡体脂沉积的影响。以东北农业大学高、低脂双向选择品系肉鸡为材料,采用PCR-RFLP方法检测ACOX3基因的多态性,并分析该基因多态性与鸡脂肪性状的关系。结果表明,ACOX3基因c.-228C>T突变位点在肉鸡高、低脂双向选择品系第10、11世代混合群体中,对腹脂重、腹脂率和血浆VLDL浓度有显著影响(P<0.05);c.-442A>C突变位点在第8-11世代混合群体低脂系中,对腹脂重有显著影响(P<0.05);c.27035A>G突变位点在第10、11世代混合群体低脂系中,对血浆VLDL浓度有显著影响(P<0.05);c.16802C>T突变位点在第11世代低脂系中,对腹脂重、腹脂率有显著影响(P<0.05)。结果显示,ACOX3基因对鸡的体脂沉积有重要影响。ACOX3基因c.-228C>T突变位点对鸡脂肪性状有显著影响,可以尝试作为遗传标记对脂肪性状进行分子标记辅助选择。展开更多
Background:Non-alcoholic fatty liver disease(NAFLD)is one of the most prevalent chronic liver diseases.However,the exact pathogenesis of NAFLD remains to be elucidated.Despite the association with tumors and cardiovas...Background:Non-alcoholic fatty liver disease(NAFLD)is one of the most prevalent chronic liver diseases.However,the exact pathogenesis of NAFLD remains to be elucidated.Despite the association with tumors and cardiovascular diseases,the role of miR-222 in NAFLD remains unclear.The present study was to investigate the role of miR-222 in NAFLD.Methods:Wild-type C57BL/6 mice were fed a high-fat diet for 12 weeks to induce NAFLD.Normal human liver cell line(L02)was cultured with free fatty acid(FFA)-containing medium to stimulate cell steatosis.The mRNA levels of miR-222 and acyl Coenzyme A xidase 1(ACOX1)were detected by quantitative-PCR(Q-PCR).The prediction of ACOX1 as the target gene for miR-222 was conducted via TargetScan.The overexpression or inhibition of miR-222 was mediated by miR-222 mimics or antagomir,and intracellular triglyceride levels were measured using a triglyceride kit.Luciferase reporter assays verified ACOX1 as the target gene for miR-222.Results:miR-222 was significantly elevated in both the in vivo and in vitro NAFLD models.Overexpression of miR-222 significantly increased triglyceride content in the L02 cells,while inhibition of miR-222 expression restricted the accumulation of triglyceride.Overexpression of miR-222 significantly inhibited ACOX1 expression.Transient transfection assays verified that ACOX1 3-UTR luciferase reporter activity could be inhibited by miR-222 overexpression.Conclusions:The present study suggested that miR-222 promotes the accumulation of triglycerides by inhibiting ACOX1.展开更多
Elevation of serum transaminases is a frequent cause of consultation in hepatology departments.1 The most common causes of hypertransaminasemia are alcoholic and metabolic dysfunction–associated steatotic liver disea...Elevation of serum transaminases is a frequent cause of consultation in hepatology departments.1 The most common causes of hypertransaminasemia are alcoholic and metabolic dysfunction–associated steatotic liver disease,viral infections,autoimmune liver disease,celiac disease,iron overload,Wilson’s disease,and exposure to toxic compounds,including drugs.2 Although serum biochemistry,serological methods,functional approaches,imaging techniques,and liver biopsy can help to identify the etiology of liver damage,up to 15%of hypertransaminasemia cases in adults3 and 13%in children4 remain idiopathic.展开更多
Rare neurological diseases,while individually are rare,collectively impact millions globally,leading to diverse and often severe neurological symptoms.Often attributed to genetic mutations that disrupt protein functio...Rare neurological diseases,while individually are rare,collectively impact millions globally,leading to diverse and often severe neurological symptoms.Often attributed to genetic mutations that disrupt protein function or structure,understanding their genetic basis is crucial for accurate diagnosis and targeted therapies.To investigate the underlying pathogenesis of these conditions,researchers often use non-mammalian model organisms,such as Drosophila(fruit flies),which is valued for their genetic manipulability,cost-efficiency,and preservation of genes and biological functions across evolutionary time.Genetic tools available in Drosophila,including CRISPR-Cas9,offer a means to manipulate gene expression,allowing for a deep exploration of the genetic underpinnings of rare neurological diseases.Drosophila boasts a versatile genetic toolkit,rapid generation turnover,and ease of large-scale experimentation,making it an invaluable resource for identifying potential drug candidates.Researchers can expose flies carrying disease-associated mutations to various compounds,rapidly pinpointing promising therapeutic agents for further investigation in mammalian models and,ultimately,clinical trials.In this comprehensive review,we explore rare neurological diseases where fly research has significantly contributed to our understanding of their genetic basis,pathophysiology,and potential therapeutic implications.We discuss rare diseases associated with both neuron-expressed and glial-expressed genes.Specific cases include mutations in CDK19 resulting in epilepsy and developmental delay,mutations in TIAM1 leading to a neurodevelopmental disorder with seizures and language delay,and mutations in IRF2BPL causing seizures,a neurodevelopmental disorder with regression,loss of speech,and abnormal movements.And we explore mutations in EMC1 related to cerebellar atrophy,visual impairment,psychomotor retardation,and gain-of-function mutations in ACOX1 causing Mitchell syndrome.Loss-of-function mutations in ACOX1 result in ACOX1 deficiency,characterized by very-long-chain fatty acid accumulation and glial degeneration.Notably,this review highlights how modeling these diseases in Drosophila has provided valuable insights into their pathophysiology,offering a platform for the rapid identification of potential therapeutic interventions.Rare neurological diseases involve a wide range of expression systems,and sometimes common phenotypes can be found among different genes that cause abnormalities in neurons or glia.Furthermore,mutations within the same gene may result in varying functional outcomes,such as complete loss of function,partial loss of function,or gain-of-function mutations.The phenotypes observed in patients can differ significantly,underscoring the complexity of these conditions.In conclusion,Drosophila represents an indispensable and cost-effective tool for investigating rare neurological diseases.By facilitating the modeling of these conditions,Drosophila contributes to a deeper understanding of their genetic basis,pathophysiology,and potential therapies.This approach accelerates the discovery of promising drug candidates,ultimately benefiting patients affected by these complex and understudied diseases.展开更多
本研究旨在对陆川猪脂酰辅酶A氧化酶1(acyl-coenzyme A oxidase 1,ACOX1)基因进行克隆及生物信息学分析。根据GenBank中猪ACOX1基因序列设计特异性引物,利用RT-PCR技术对陆川猪ACOX1基因进行克隆、测序和生物信息学分析。结果表明,陆川...本研究旨在对陆川猪脂酰辅酶A氧化酶1(acyl-coenzyme A oxidase 1,ACOX1)基因进行克隆及生物信息学分析。根据GenBank中猪ACOX1基因序列设计特异性引物,利用RT-PCR技术对陆川猪ACOX1基因进行克隆、测序和生物信息学分析。结果表明,陆川猪ACOX1基因CDS全长1 986bp,编码661个氨基酸,陆川猪ACOX1基因与猪、牛、人、斑马鱼、鸡、猕猴、大鼠、小鼠、爪蟾序列同源性分别为99.5%、85.5%、87.1%、66.3%、75.6%、84.0%、82.3%、81.1%和69.1%。系统进化树分析结果表明,ACOX1基因在不同物种及进化的过程中具有高度保守性,蛋白质二级结构预测结果表明,陆川猪ACOX1蛋白没有信号肽,没有形成跨膜结构。本研究成功克隆了陆川猪ACOX1基因,为阐明其在陆川猪脂肪沉积及代谢方面的调控研究奠定了理论基础。展开更多
文摘文章通过分析酰基辅酶A氧化酶(Acyl-Coenzyme A Oxidases 3,ACOX3)基因单核苷酸多态性与鸡脂肪性状的关系,旨在了解该基因对鸡体脂沉积的影响。以东北农业大学高、低脂双向选择品系肉鸡为材料,采用PCR-RFLP方法检测ACOX3基因的多态性,并分析该基因多态性与鸡脂肪性状的关系。结果表明,ACOX3基因c.-228C>T突变位点在肉鸡高、低脂双向选择品系第10、11世代混合群体中,对腹脂重、腹脂率和血浆VLDL浓度有显著影响(P<0.05);c.-442A>C突变位点在第8-11世代混合群体低脂系中,对腹脂重有显著影响(P<0.05);c.27035A>G突变位点在第10、11世代混合群体低脂系中,对血浆VLDL浓度有显著影响(P<0.05);c.16802C>T突变位点在第11世代低脂系中,对腹脂重、腹脂率有显著影响(P<0.05)。结果显示,ACOX3基因对鸡的体脂沉积有重要影响。ACOX3基因c.-228C>T突变位点对鸡脂肪性状有显著影响,可以尝试作为遗传标记对脂肪性状进行分子标记辅助选择。
基金supported by grants from the National Natu-ral Science Foundation of China(81420108005 and 81630016)the Natural Science Foundation and Major Basic Research Program of Shanghai(16JC1420104)the Ministry of Science and Technol-ogy of China(2013CB945401)
文摘Background:Non-alcoholic fatty liver disease(NAFLD)is one of the most prevalent chronic liver diseases.However,the exact pathogenesis of NAFLD remains to be elucidated.Despite the association with tumors and cardiovascular diseases,the role of miR-222 in NAFLD remains unclear.The present study was to investigate the role of miR-222 in NAFLD.Methods:Wild-type C57BL/6 mice were fed a high-fat diet for 12 weeks to induce NAFLD.Normal human liver cell line(L02)was cultured with free fatty acid(FFA)-containing medium to stimulate cell steatosis.The mRNA levels of miR-222 and acyl Coenzyme A xidase 1(ACOX1)were detected by quantitative-PCR(Q-PCR).The prediction of ACOX1 as the target gene for miR-222 was conducted via TargetScan.The overexpression or inhibition of miR-222 was mediated by miR-222 mimics or antagomir,and intracellular triglyceride levels were measured using a triglyceride kit.Luciferase reporter assays verified ACOX1 as the target gene for miR-222.Results:miR-222 was significantly elevated in both the in vivo and in vitro NAFLD models.Overexpression of miR-222 significantly increased triglyceride content in the L02 cells,while inhibition of miR-222 expression restricted the accumulation of triglyceride.Overexpression of miR-222 significantly inhibited ACOX1 expression.Transient transfection assays verified that ACOX1 3-UTR luciferase reporter activity could be inhibited by miR-222 overexpression.Conclusions:The present study suggested that miR-222 promotes the accumulation of triglycerides by inhibiting ACOX1.
基金funded by Instituto de Salud Carlos Ⅲ(PI22/00526),co-funded by the European Unionthe Ministry of Science and Innovation through the grant PID2022-140210OB-I00+2 种基金CIBERehd(EHD15PI05/2016)CIBEResp(ESP23PI08)the“Junta de Castilla y León”(SA113P23),Spain.
文摘Elevation of serum transaminases is a frequent cause of consultation in hepatology departments.1 The most common causes of hypertransaminasemia are alcoholic and metabolic dysfunction–associated steatotic liver disease,viral infections,autoimmune liver disease,celiac disease,iron overload,Wilson’s disease,and exposure to toxic compounds,including drugs.2 Although serum biochemistry,serological methods,functional approaches,imaging techniques,and liver biopsy can help to identify the etiology of liver damage,up to 15%of hypertransaminasemia cases in adults3 and 13%in children4 remain idiopathic.
基金supported by Warren Alpert Foundation and Houston Methodist Academic Institute Laboratory Operating Fund(to HLC).
文摘Rare neurological diseases,while individually are rare,collectively impact millions globally,leading to diverse and often severe neurological symptoms.Often attributed to genetic mutations that disrupt protein function or structure,understanding their genetic basis is crucial for accurate diagnosis and targeted therapies.To investigate the underlying pathogenesis of these conditions,researchers often use non-mammalian model organisms,such as Drosophila(fruit flies),which is valued for their genetic manipulability,cost-efficiency,and preservation of genes and biological functions across evolutionary time.Genetic tools available in Drosophila,including CRISPR-Cas9,offer a means to manipulate gene expression,allowing for a deep exploration of the genetic underpinnings of rare neurological diseases.Drosophila boasts a versatile genetic toolkit,rapid generation turnover,and ease of large-scale experimentation,making it an invaluable resource for identifying potential drug candidates.Researchers can expose flies carrying disease-associated mutations to various compounds,rapidly pinpointing promising therapeutic agents for further investigation in mammalian models and,ultimately,clinical trials.In this comprehensive review,we explore rare neurological diseases where fly research has significantly contributed to our understanding of their genetic basis,pathophysiology,and potential therapeutic implications.We discuss rare diseases associated with both neuron-expressed and glial-expressed genes.Specific cases include mutations in CDK19 resulting in epilepsy and developmental delay,mutations in TIAM1 leading to a neurodevelopmental disorder with seizures and language delay,and mutations in IRF2BPL causing seizures,a neurodevelopmental disorder with regression,loss of speech,and abnormal movements.And we explore mutations in EMC1 related to cerebellar atrophy,visual impairment,psychomotor retardation,and gain-of-function mutations in ACOX1 causing Mitchell syndrome.Loss-of-function mutations in ACOX1 result in ACOX1 deficiency,characterized by very-long-chain fatty acid accumulation and glial degeneration.Notably,this review highlights how modeling these diseases in Drosophila has provided valuable insights into their pathophysiology,offering a platform for the rapid identification of potential therapeutic interventions.Rare neurological diseases involve a wide range of expression systems,and sometimes common phenotypes can be found among different genes that cause abnormalities in neurons or glia.Furthermore,mutations within the same gene may result in varying functional outcomes,such as complete loss of function,partial loss of function,or gain-of-function mutations.The phenotypes observed in patients can differ significantly,underscoring the complexity of these conditions.In conclusion,Drosophila represents an indispensable and cost-effective tool for investigating rare neurological diseases.By facilitating the modeling of these conditions,Drosophila contributes to a deeper understanding of their genetic basis,pathophysiology,and potential therapies.This approach accelerates the discovery of promising drug candidates,ultimately benefiting patients affected by these complex and understudied diseases.
文摘本研究旨在对陆川猪脂酰辅酶A氧化酶1(acyl-coenzyme A oxidase 1,ACOX1)基因进行克隆及生物信息学分析。根据GenBank中猪ACOX1基因序列设计特异性引物,利用RT-PCR技术对陆川猪ACOX1基因进行克隆、测序和生物信息学分析。结果表明,陆川猪ACOX1基因CDS全长1 986bp,编码661个氨基酸,陆川猪ACOX1基因与猪、牛、人、斑马鱼、鸡、猕猴、大鼠、小鼠、爪蟾序列同源性分别为99.5%、85.5%、87.1%、66.3%、75.6%、84.0%、82.3%、81.1%和69.1%。系统进化树分析结果表明,ACOX1基因在不同物种及进化的过程中具有高度保守性,蛋白质二级结构预测结果表明,陆川猪ACOX1蛋白没有信号肽,没有形成跨膜结构。本研究成功克隆了陆川猪ACOX1基因,为阐明其在陆川猪脂肪沉积及代谢方面的调控研究奠定了理论基础。
